Rebecca Lopez, PHD

Texas Tech University Health Sciences
Center of Excellence in Cancer and Center of Excellence in Diabetes Research
Blockade Of Growth Hormone Receptor Inhibits HER2 Overexpressing Breast Cancer Cell Proliferation
Progesterone activates USF-1 in estrogen induced mammary carcinogenesis
Persistent alteration of microRNA expression in hypothalamo-pituitary axis results in the reduction of breast cancer risk
In vitro conditions that mimic diabetes and obesity enhance proliferation of both non-tumorigenic and malignant breast epithelial cells through increased leptin signaling and activation of PI3K and AKT signaling pathways